Promoter group entities of manipal health enterprises limited have pledged 6,31,70,773 equity shares to secure non-convertible debentures (NCDs) issued by associated private limited companies. This disclosure, made under Regulation 29(1) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, reveals that Vistra ITCL (India) Limited has been appointed as the common security trustee for these transactions. The pledge was created on August 5, 2026, shortly after the company’s listing on August 5, 2026, impacting approximately 4.80% of the total share capital and 4.74% on a fully diluted basis.

The encumbrance secures three separate tranches of unlisted, secured NCDs totaling INR 9,420 crore. These include INR 6,500 crore issued by Claypond Capital Partners Private Limited, INR 2,305 crore issued by Manipal Healthcare Private Limited (which has amalgamated into MEMG India), and INR 615 crore issued by Manipal Education and Medical Group India Private Limited. Vistra ITCL (India) Limited acts as the debenture trustee for each facility and as the common security trustee for the benefit of all respective debenture holders.

Share Pledge Details

The pledge is structured across two promoter group entities: Manipal Education and Medical Group India Private Limited (MEMG India) and MEMGIPL. The specific share counts and percentage holdings are detailed below.

In addition to the direct pledge, a larger block of shares remains encumbered through covenants. A total of 36,90,38,332 shares, representing 28.06% of the total share capital and 27.70% on a fully diluted basis, are subject to encumbrances via covenants agreed upon by MEMG India, MEMGIPL, and promoter Ranjan Pai. These covenants are part of the broader security structure supporting the NCD facilities.

Regulatory Framework and Trust Deeds

The security arrangements are governed by multiple amended trust deeds. The Claypond Capital Partners facility is secured under a debenture trust deed originally dated December 3, 2025, with subsequent amendments on January 21, 2026, and July 8, 2026. The Manipal Healthcare Private Limited facility relies on a trust deed originally dated July 10, 2023, which has been amended four times, most recently on August 3, 2026. The MEMG India facility is governed by a trust deed dated November 3, 2023.

The common security trustee agreement, initially dated July 10, 2023, was further amended and restated on April 4, 2024, January 21, 2026, and July 8, 2026. This agreement consolidates the security interests for the benefit of all debenture holders across the three NCD issuances. Personal guarantees provided by Ranjan Pai also form part of the security package for these debt instruments.

What the Numbers Show

The concentration of encumbrances highlights a significant linkage between the listed entity’s equity and the debt obligations of its promoter group. While only 4.80% of shares are directly pledged, the additional 23.26% of shares subject to covenants indicates that nearly 28% of the company’s voting power is tied to the repayment security of off-balance-sheet debt held by related private entities. This structure suggests that the financial health of the promoter group’s debt obligations is directly supported by the equity value of Manipal Health Enterprises Limited.

Deutsche Bank AG, Singapore Branch, acting as agent and offshore security agent, disclosed the creation of an encumbrance over a significant portion of manipal health enterprises limited 's promoter-held equity shares. The disclosure, filed under Regulation 29(1) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, reveals that 286,443,818 shares are now encumbered, representing 21.78% of the issued and paid-up share capital and 21.50% on a fully diluted basis. This move secures a term loan facility for key promoter entities, impacting the liquidity and transferability of these stakes.

The encumbrance stems from a facility agreement dated May 20, 2025, entered into by Manipal Global Health Services ("Borrower 1") and Cypress Holdings ("Borrower 2"). Deutsche Bank AG, Singapore Branch, acts as both the Agent and the Offshore Security Agent for the lenders. Axis Trustee Services Limited, Gift City Branch, serves as the Onshore Security Agent. The charges were created to secure the term loan facility availed by the Borrowers.

The structure involves indirect charges over the target company's shares through parent entities. MEMG International Ltd ("MEMGI"), the parent of Borrower 1, created a charge on 100% of Borrower 1's share capital via a deed dated May 22, 2025. Similarly, Borrower 1 created a charge on 100% of Borrower 2's share capital via a deed dated July 2, 2025. Additionally, MEMGI created a charge on 100% of Manipal Research & Management Services International ("MRMSI")'s share capital on May 22, 2025. These actions result in indirect charges over the shares held by these entities in Manipal Health Enterprises Limited.

In addition to the fixed and floating charges, the Borrowers provided covenants in favor of the Agent and Offshore Security Agent regarding the equity shares held by them and MRMSI. These covenants constitute encumbrances covering 21.50% of the share capital on a fully diluted basis, including employee stock option plan pool options outstanding. The disclosure treats these encumbrances as an acquisition under Regulation 29(1) read with Regulation 29(4) of the Takeover Code.

What the Numbers Show

The encumbrance covers the entire shareholding of the three key promoter entities mentioned: Manipal Global Health Services, Cypress Holdings, and MRMSI. With 21.78% of the total voting power now pledged, any default on the term loan could lead to a change in control or significant dilution of promoter interests. The use of indirect charges through parent companies (MEMGI and Borrower 1) suggests a structured financing arrangement designed to secure debt while maintaining operational control at the subsidiary level until potential distress events occur. The total diluted holding remains unchanged at 1,332,067,702 shares, indicating no new issuance but rather a restriction on existing float.